loss-of-function tolerance and nonessentiality of the SH3 domain. 3 The other allegedly RP-associated variant reported by Huang et al., p.Y218C, is described as being "located in a highly conserved region. " This claim is based on a peptide alignment with mammals only rather than with nonmammalian species and is therefore not convincing. The p.Y218C variant is re-presented with 64 alleles in the ExAC database, albeit not in a homozygous state. Although this does not exclude pathogenicity for a recessive allele, it is thus much more likely that p.Y218C, like p.E1086G, is a benign variant.
Assessing the pathogenicity of genetic variants requires the utmost caution because their inclusion in databases-and thus potentially in diagnostic, prenatal, and carrier testing-has far-reaching consequences. This may, as demonstrated by rare AHI1 truncations without clinical consequences, 3 pose a challenge. However, in the case of the two AHI1 variants described by Huang et al., the evidence-particularly their high frequencies in the general population-calls their pathogenicity into question. 
